McKessonPrefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
| Period | GLP-1 distribution revenue ($B) | YoY change (%) |
|---|---|---|
| FY 2026 | 53 | 27 |
| Period | GLP-1 distribution revenue ($B) | YoY change (%) | Sequential change (%) |
|---|---|---|---|
| Q4 FY2026 | 14 | 22 | -4 |
| Period | Patient savings ($B, printed) |
|---|---|
| FY 2026 | 10 |
| Period | Patients supported (millions) |
|---|---|
| FY 2026 verification season | 3.4 |
| Segment | Revenue ($M) | Operating profit, GAAP ($M) | Operating profit, adjusted ($M) |
|---|---|---|---|
| North American Pharmaceutical | 79,120 | 1,157 | 980 |
| Oncology & Multispecialty | 12,711 | 301 | 385 |
| Prescription Technology Solutions | 1,495 | 286 | 322 |
| Medical-Surgical Solutions | 2,868 | 232 | 271 |
| Other | 101 | 518 | 8 |
| Total | 96,295 | 2,494 | 1,966 |
| Period | |
|---|---|
| US Oncology Network FY 2026 | More than 570 providers added |
| PRISM Vision | Providers up about 20% over the past year |